Advertisement
Advertisement
U.S. markets closed
Advertisement
Advertisement
Advertisement
Advertisement

Salarius Pharmaceuticals, Inc. (SLRX)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.2059+0.0109 (+5.59%)
At close: 04:00PM EDT
0.2001 -0.01 (-2.82%)
After hours: 07:43PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bearishpattern detected
Momentum

Momentum

Previous Close0.1950
Open0.2002
Bid0.2001 x 900
Ask0.2059 x 2200
Day's Range0.1982 - 0.2150
52 Week Range0.1600 - 1.2000
Volume233,907
Avg. Volume1,133,680
Market Cap11.554M
Beta (5Y Monthly)1.86
PE Ratio (TTM)N/A
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
XX.XX
Overvalued

Subscribe to Yahoo Finance Plus to view Fair Value for SLRX

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Salarius Pharmaceuticals, Inc.
    CYTK: Raising target price to $46.00CYTOKINETICS INC has an Investment Rating of HOLD; a target price of $46.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Low; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of Low.
    Rating
    Fair Value
    Economic Moat
    6 days agoArgus Research
View more
Advertisement
Advertisement